Related Experiment Video
Updated: Jan 23, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Emerging Biomarkers in Vascular Cognitive Impairment and Dementia: From Pathophysiological Pathways to Clinical
Virginia Cipollini1, Fernanda Troili2, Franco Giubilei3
1S. Andrea Hospital, NESMOS Department, Faculty of Medicine and Psychology, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Roma, Italy. virginia.cipollini@gmail.com.
Insights
Small vessel disease (SVD) is a key cause of vascular cognitive impairment and dementia (VCID). This review explores VCID
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Vascular pathology is the second leading cause of dementia, with small vessel disease (SVD) being the primary driver of vascular cognitive impairment and dementia (VCID).
- Understanding the pathophysiological mechanisms of VCID is crucial for developing effective diagnostic and therapeutic strategies.
Purpose of the Study:
- To review the underlying pathophysiological pathways of vascular cognitive impairment and dementia (VCID).
- To examine the role of endothelial dysfunction, blood-brain barrier disruption, and neuroinflammation in VCID pathogenesis.
- To analyze various biomarkers, including those related to central nervous system injury, coagulation, thrombosis, and microRNA, for VCID diagnosis.
Main Methods:
- Literature review focusing on pathophysiological mechanisms of VCID.
- Analysis of existing research on endothelial dysfunction, blood-brain barrier integrity, and neuroinflammation in VCID.
- Evaluation of current and potential biomarkers for VCID, including inflammatory, coagulation, thrombosis, and microRNA markers.
Main Results:
- Endothelial dysfunction, blood-brain barrier disruption, and neuroinflammation are central to VCID pathogenesis.
- Biomarkers for inflammatory responses, coagulation, thrombosis, and circulating microRNA show potential for VCID assessment.
- Current evidence for peripheral biomarkers in VCID is limited, necessitating further research.
Conclusions:
- VCID pathogenesis involves complex interactions between vascular factors, inflammation, and neuronal injury.
- Biomarker research is essential for improving the differential diagnosis of dementia types.
- Large-scale, prospective studies are required to validate peripheral biomarkers and translate findings into clinical practice for VCID.
Abstract:
Vascular pathology is the second most common neuropathology of dementia after Alzheimer's disease (AD), with small vessels disease (SVD) being considered the major cause of vascular cognitive impairment and dementia (VCID). This review aims to evaluate pathophysiological pathways underlying a diagnosis of VCID. Firstly, we will discuss the role of endothelial dysfunction, blood-brain barrier disruption and neuroinflammation in its pathogenesis. Then, we will analyse different biomarkers including the ones of inflammatory responses to central nervous system tissue injuries, of coagulation and thrombosis and of circulating microRNA. Evidences on peripheral biomarkers for VCID are still poor and large-scale, prospectively designed studies are needed to translate these findings into clinical practice, in order to set different combinations of biomarkers to use for differential diagnosis among types of dementia.
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Applications of GIS: Disaster Management and Emergency Response
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Cognitive Dissonance
Clinical Applications of Epidermal Stem Cells

